Insufficient scRNA-seq data for expression of INSRR at single-cell level.
Insufficient scRNA-seq data for expression of INSRR at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 60% | 117.81 | 156 / 258 | 63% | 16.33 | 145 / 230 |
uterus | 98% | 246.43 | 167 / 170 | 11% | 0.45 | 51 / 459 |
kidney | 99% | 806.88 | 88 / 89 | 7% | 0.19 | 60 / 901 |
prostate | 98% | 195.12 | 239 / 245 | 6% | 0.15 | 31 / 502 |
stomach | 97% | 337.70 | 350 / 359 | 2% | 0.05 | 5 / 286 |
thymus | 83% | 44.15 | 541 / 653 | 7% | 0.33 | 40 / 605 |
pancreas | 77% | 34.29 | 252 / 328 | 10% | 0.21 | 17 / 178 |
breast | 76% | 78.37 | 351 / 459 | 4% | 0.15 | 49 / 1118 |
heart | 80% | 40.11 | 693 / 861 | 0% | 0 | 0 / 0 |
adipose | 67% | 79.95 | 810 / 1204 | 0% | 0 | 0 / 0 |
brain | 52% | 71.15 | 1377 / 2642 | 13% | 0.42 | 95 / 705 |
intestine | 61% | 29.93 | 588 / 966 | 2% | 0.05 | 10 / 527 |
esophagus | 43% | 17.79 | 615 / 1445 | 2% | 0.07 | 3 / 183 |
spleen | 33% | 9.31 | 79 / 241 | 0% | 0 | 0 / 0 |
ovary | 23% | 15.13 | 42 / 180 | 6% | 0.16 | 25 / 430 |
bladder | 24% | 8.62 | 5 / 21 | 2% | 0.32 | 8 / 504 |
lung | 22% | 7.74 | 127 / 578 | 2% | 0.07 | 20 / 1155 |
blood vessel | 18% | 6.79 | 245 / 1335 | 0% | 0 | 0 / 0 |
muscle | 17% | 5.06 | 137 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 14% | 5.25 | 133 / 929 | 0% | 0 | 0 / 0 |
skin | 7% | 2.57 | 124 / 1809 | 1% | 0.03 | 7 / 472 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.10 | 2 / 45 |
liver | 1% | 0.37 | 3 / 226 | 1% | 0.06 | 4 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0033674 | Biological process | positive regulation of kinase activity |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0007275 | Biological process | multicellular organism development |
GO_0071469 | Biological process | cellular response to alkaline pH |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0030238 | Biological process | male sex determination |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
GO_0005899 | Cellular component | insulin receptor complex |
GO_0030424 | Cellular component | axon |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005009 | Molecular function | insulin receptor activity |
GO_0005524 | Molecular function | ATP binding |
GO_0043548 | Molecular function | phosphatidylinositol 3-kinase binding |
GO_0005515 | Molecular function | protein binding |
GO_0043560 | Molecular function | insulin receptor substrate binding |
GO_0004714 | Molecular function | transmembrane receptor protein tyrosine kinase activity |
Gene name | INSRR |
Protein name | Insulin receptor-related protein (IRR) (EC 2.7.10.1) (IR-related receptor) [Cleaved into: Insulin receptor-related protein alpha chain; Insulin receptor-related protein beta chain] receptor protein-tyrosine kinase (EC 2.7.10.1) |
Synonyms | IRR |
Description | FUNCTION: Receptor with tyrosine-protein kinase activity. Functions as a pH sensing receptor which is activated by increased extracellular pH. Activates an intracellular signaling pathway that involves IRS1 and AKT1/PKB. . |
Accessions | I6U4P1 P14616 ENST00000368195.4 |